Interaction between Hyperuricemia and Admission Lactate Increases the Risk of Acute Kidney Injury in Patients with ST-Segment Elevation Myocardial Infarction

Abstract

<b><i>Background and Objective:</i></b> Acute kidney injury (AKI) is a common complication associated with adverse outcomes among patients with ST-segment elevation myocardial infarction (STEMI). This is conflicting information about the relationship between hyperuricemia and AKI in STEMI. This work aimed to investigate the effect of the interaction between hyperuricemia and lactate on the risk of AKI. <b><i>Methods:</i></b> We analyzed 2,008 consecutive STEMI patients between January 2014 and January 2019. Hyperuricemia was defined as a serum uric acid level &#x3e;7 mg/dL for males and &#x3e;6 mg/dL for females. AKI was defined based on the Kidney Disease: Improving Global Outcomes (KDIGO). Logistic regression models were applied to establish the relationship between hyperuricemia and AKI in the overall population and subgroups stratified as per lactate levels at admission (≤2.2 mmol/L or &#x3e;2.2 mmol/L). <b><i>Results:</i></b> In total, we included 1,887 STEMI patients. Multivariate analysis showed that hyperuricemia is associated with the risk of AKI (OR: 1.34; 95% CI: 1.01–1.77; <i>p</i> = 0.045). Nonetheless, the predictive effect of hyperuricemia was only observed in patients with lactate level &#x3e;2.2 mmol/L (OR: 2.05; 95% CI: 1.36–3.10; <i>p</i> &#x3c; 0.001), but not in those with lactate level ≤2.2 mmol/L (OR: 0.86, 95% CI: 0.56–1.32; <i>p</i> = 0.493). The interaction between hyperuricemia and lactate levels demonstrated a significant effect on AKI. <b><i>Conclusions:</i></b> In summary, hyperuricemia increases the risk of AKI in STEMI patients with lactate levels&#x3e; 2.2 mmol/L, but not in those with lactate levels ≤2.2 mmol/L.